Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Medical - Devices

Healthcare
$1.20 -6.72%

-$0.09 today

Market cap
$50.65M
Beta
-1.23
P/E (TTM)
-1.3
EPS (TTM)
-$0.94
52W Low $0.76High $7.26

Volume 0.02M

Average 0.37M

BDMD Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Baird Medical Investment Holdings LimitedNASDAQ: BDMD

Gross Profit · Q4 FY2025 · quarter ended Dec 2025

Gross profit declines year over year

Q4 FY2025 gross profit of $12.35M fell 41.6% year over year. Over 3 fiscal years it compounded at -12.3% a year.

Context

  • Gross profit amounted to 83.8% of revenue in FY2025, down 4.4 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
$12.35M— QoQ
Last fiscal yearDec 2025
$18.88M-42.2% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-41.6%——
1 year-42.2%——
3-year CAGR-12.3%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
18.88M USD
Year-over-year change
-42.2%
4-year CAGR
-5.0%

Gross Profit vs competitors

How BDMD compares with its peers on the latest reported figures

  • BDMD's FY2025 gross profit of $18.88M is the 3rd highest of the 4 companies compared; the peer median is $30.45M.
  • Its year-over-year change of -42.2% is the 3rd highest of 4, against a peer median of +35.0%.
  • Gross profit amounts to 83.8% of revenue for BDMD, versus a peer median of 84.7%.
BDMD Competitors Peer median
Gross Profit for BDMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BDSXBiodesix, Inc.LTM Mar 2026$78.88M +35.1%+44.0%82.1%
ECORelectroCore, Inc.LTM Mar 2026$30.45M +35.0%+58.5%87.2%
BDMDBaird Medical Investment Holdings LimitedFY2025$18.88M -42.2%-12.3%83.8%
OKUROnKure Therapeutics, Inc.LTM Mar 2026-$203K -1591.7%——
Peer median (excluding BDMD) $30.45M+35.0%+51.2%84.7%

Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.72M35.09M31.46M37.04M22.54M
Cost of Revenue4.54M7.05M4.23M4.38M3.65M
Gross Profit23.18M28.04M27.23M32.65M18.88M
Gross Margin83.6%79.9%86.6%88.2%83.8%
Research & Development1.04M3.86M4.27M6.17M20.13M
Selling, General & Admin10.22M10.55M11.09M9.96M24.38M
Operating Expenses9.76M13.03M15.37M17.34M44.42M
Depreciation & Amortization1.4M1.47M1.01M1.51M1.1M
EBITDA14.16M16.29M12.88M16.17M(24.53M)
EBITDA Margin51.1%46.4%40.9%43.7%-108.9%
Operating Income11.92M13.63M11.86M15.32M(25.54M)
Operating Margin43.0%38.8%37.7%41.4%-113.3%
Interest Income2.33K8.55K03930
Interest Expense153.92K299.27K284.27K576.75K737.37K
Other Income / Expenses688.35K890.15K497.48K(1.23M)(837.57K)
Income Before Tax12.61M14.52M12.36M14.09M(26.37M)
Pre-Tax Margin45.5%41.4%39.3%38.0%-117.0%
Income Tax Expense2.42M1.75M1.7M1.49M1.17M
Net Income11.68M12.57M10.55M12.45M(27.28M)
Net Margin42.1%35.8%33.5%33.6%-121.0%
EPS (Basic)(0.02)0.020.410.49(0.98)
EPS (Diluted)(0.02)0.020.410.49(0.98)
Weighted Avg Shares7.19M6.29M7.58M25.56M27.79M
Weighted Avg Shares (Diluted)7.19M7.19M7.58M25.63M27.79M

Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Intrinsic Alpha fair value

Locked

Current Price

$1.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.